{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:16:07Z","timestamp":1772129767690,"version":"3.50.1"},"reference-count":55,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Commission","award":["JUST\/2013\/DPIP\/AG\/4823"],"award-info":[{"award-number":["JUST\/2013\/DPIP\/AG\/4823"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background: illegal drugs significantly contribute to global health issues, with health complications often occurring not only in regular users with Substance Use Disorders (SUDs) but also in first-time and occasional users. Methods: this study examines five clinical cases from a public hospital in Ibiza, Spain, where patients presented with acute psychiatric symptoms due to recreational drug use. Results: Contrary to previous studies on SUDs, our patients typically had higher education levels and stable employment. Most of them used multiple substances, with cannabis, cocaine, and alcohol being the most frequently used. There was also a common occurrence of consuming drugs with uncertain contents. Upon admission, typical symptoms included aggression, hallucinations, mood swings, and disorientation in time and space. Conclusions: Our findings underscore the significant mental health risks posed by illicit drugs, even for individuals with no prior psychiatric history. Factors like the drug\u2019s potency, frequency and amount of use, past mental health issues, personality traits, and previous traumatic experiences might influence the onset of these symptoms.<\/jats:p>","DOI":"10.3390\/ph17101387","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T11:19:18Z","timestamp":1729163958000},"page":"1387","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Club Drugs and Psychiatric Outcomes: A Descriptive Case Series from Spain"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3280-1895","authenticated-orcid":false,"given":"Chiara","family":"Montemitro","sequence":"first","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, G. D\u2019Annunzio University of Chieti, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3832-1398","authenticated-orcid":false,"given":"Alessio","family":"Mosca","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, G. D\u2019Annunzio University of Chieti, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6810-1540","authenticated-orcid":false,"given":"Stefania","family":"Chiappini","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, G. D\u2019Annunzio University of Chieti, 66100 Chieti, Italy"},{"name":"School of Medicine, UniCamillus International Medical School University, Via di S. Alessandro 8, 00131 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2431-0460","authenticated-orcid":false,"given":"Andrea","family":"Miuli","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, G. D\u2019Annunzio University of Chieti, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4178-5401","authenticated-orcid":false,"given":"Fabrizio","family":"Schifano","sequence":"additional","affiliation":[{"name":"Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jos\u00e8 Gordillo","family":"Montano","sequence":"additional","affiliation":[{"name":"Hospital Can Misses Hospital, 07800 Eivissa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Merino del","family":"Villar","sequence":"additional","affiliation":[{"name":"Hospital Can Misses Hospital, 07800 Eivissa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Allegretti","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, G. D\u2019Annunzio University of Chieti, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlotta","family":"Marrangone","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, G. D\u2019Annunzio University of Chieti, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilberto","family":"Di Petta","sequence":"additional","affiliation":[{"name":"Mental Health Department, Santa Maria delle Grazie Hospital, ASL 2, 80078 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4415-5058","authenticated-orcid":false,"given":"Domenico","family":"De Berardis","sequence":"additional","affiliation":[{"name":"Department of Mental Health, ASL, 64100 Teramo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4164-3040","authenticated-orcid":false,"given":"Mauro","family":"Pettorruso","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, G. D\u2019Annunzio University of Chieti, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7292-2341","authenticated-orcid":false,"given":"Giovanni","family":"Martinotti","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, G. D\u2019Annunzio University of Chieti, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(13)61530-5","article-title":"Global burden of disease attributable to illicit drug use and dependence: Findings from the Global Burden of Disease Study 2010","volume":"382","author":"Degenhardt","year":"2013","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0306-4603(98)00073-2","article-title":"Dual diagnosis: A review of etiological theories","volume":"23","author":"Mueser","year":"1998","journal-title":"Addict. Behav."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2174\/1381612828666220623092853","article-title":"Atypical antipsychotic drugs in dual disorders: Current evidence for clinical practice","volume":"28","author":"Martinotti","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"ref_4","unstructured":"Harris, P., Nagy, S., and Vardaxis, N.J. (2014). Mosby\u2019s Dictionary of Medicine, Nursing and Health Professions, Elsevier."},{"key":"ref_5","first-page":"405","article-title":"Importance of cyberspace for the assessment of the drug abuse market: Preliminary results from the Psychonaut 2002 project","volume":"6","author":"Schifano","year":"2003","journal-title":"Cyberpsychol. Behav. Impact Internet Multimed. Virtual Real. Behav. Soc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0269881105056660","article-title":"New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 (\u2018Blue Mystic\u2019)","volume":"19","author":"Schifano","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"ref_7","first-page":"592","article-title":"Prescription Drug Misuse in \u201cClubbers\u201d and Disco Goers in Ibiza","volume":"11","author":"Negri","year":"2020","journal-title":"Front. Psychiatr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/hup.2410","article-title":"Psyclones: A roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless products","volume":"30","author":"Santacroce","year":"2015","journal-title":"Hum. Psychopharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/hup.2486","article-title":"Novel psychoactive substances: Use and knowledge among adolescents and young adults in urban and rural areas","volume":"30","author":"Martinotti","year":"2015","journal-title":"Hum. Psychopharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/02791072.2014.944291","article-title":"\u201cSpice\u201d, \u201ckryptonite\u201d, \u201cblack mamba\u201d: An overview of brand names and marketing strategies of novel psychoactive substances on the web","volume":"46","author":"Corazza","year":"2014","journal-title":"J. Psychoact. Drugs"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/7854_2016_15","article-title":"NPS: Medical Consequences Associated with Their Intake","volume":"32","author":"Schifano","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-0043-102059","article-title":"New Psychoactive Substances (NPS)\u2014A Challenge for the Addiction Treatment Services","volume":"50","author":"Scherbaum","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.coph.2021.02.008","article-title":"The e-psychonaut drugs\u2019 psychopharmacology","volume":"57","author":"Schifano","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S0033291719001727","article-title":"New\/emerging psychoactive substances and associated psychopathological consequences","volume":"51","author":"Schifano","year":"2021","journal-title":"Psychol. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bcp.14183","article-title":"How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances","volume":"86","author":"Corkey","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_16","unstructured":"ONUDD (2024, February 02). World Drug Report 2015. Available online: https:\/\/www.unodc.org\/documents\/wdr2015\/World_Drug_Report_2015.pdf."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/hup.2300","article-title":"Novel psychoactive substances as a novel challenge for health professionals: Results from an Italian survey","volume":"28","author":"Simonato","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"ref_18","unstructured":"UNODC (2024, February 02). World Drug Report 2022. Available online: https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2022.html."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jat\/bkx020","article-title":"Hair Testing for Drugs of Abuse and New Psychoactive Substances in a High-Risk Population","volume":"41","author":"Salomone","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"ref_20","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2024, February 02). Osservatorio Europeo Delle Droghe e Delle Tossicodipendenze EMCDDA. Available online: https:\/\/european-union.europa.eu\/institutions-law-budget\/institutions-and-bodies\/search-all-eu-institutions-and-bodies\/european-monitoring-centre-drugs-and-drug-addiction-emcdda_it."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/hup.2422","article-title":"Methoxetamine-related deaths in the UK: An overview","volume":"30","author":"Chiappini","year":"2015","journal-title":"Hum. Psychopharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/hup.2423","article-title":"Deaths of individuals aged 16-24\u2009years in the UK after using mephedrone","volume":"30","author":"Loi","year":"2015","journal-title":"Hum. Psychopharmacol."},{"key":"ref_23","first-page":"445","article-title":"Overview of literature and information on \u201ckhat-related\u201d mortality: A call for recognition of the issue and further research","volume":"47","author":"Corkery","year":"2011","journal-title":"Ann. Ist. Super. Sanita"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"10051","DOI":"10.3390\/ijerph111010051","article-title":"Work hard, party harder: Drug use and sexual behaviour in young British casual workers in Ibiza, Spain","volume":"11","author":"Kelly","year":"2014","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0955-3959(00)00053-0","article-title":"Ibiza uncovered: Changes in substance use and sexual behaviour amongst young people visiting an international night-life resort","volume":"11","author":"Bellis","year":"2000","journal-title":"Int. J. Drug Policy"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.drugpo.2004.01.004","article-title":"Elevated substance use in casual labour at international nightlife resorts: A case control study","volume":"15","author":"Hughes","year":"2004","journal-title":"Int. J. Drug Policy"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000189786","article-title":"Relative contributions of holiday location and nationality to changes in recreational drug taking behaviour: A natural experiment in the Balearic Islands","volume":"15","author":"Bellis","year":"2009","journal-title":"Eur. Addict. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/j.1360-0443.2003.00554.x","article-title":"The role of an international nightlife resort in the proliferation of recreational drugs","volume":"98","author":"Bellis","year":"2003","journal-title":"Addiction"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0376-8716(02)00102-3","article-title":"What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults","volume":"68","author":"Lieb","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e2592","DOI":"10.1002\/hup.2592","article-title":"A matter of life and death: Substance-caused and substance-related fatalities in Ibiza in 2015","volume":"32","author":"Santacroce","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1477-7517-8-16","article-title":"Drug Checking: A prevention measure for a heterogeneous group with high consumption frequency and polydrug use\u2014Evaluation of zurich\u2019s drug checking services","volume":"8","author":"Hungerbuehler","year":"2011","journal-title":"Harm Reduct. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0306-4603(02)00271-X","article-title":"Healthy nightclubs and recreational substance use. From a harm minimisation to a healthy settings approach","volume":"27","author":"Bellis","year":"2002","journal-title":"Addict. Behav."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2586","DOI":"10.1002\/hup.2586","article-title":"Substance-related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza","volume":"32","author":"Martinotti","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fpsyt.2020.00879","article-title":"Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients","volume":"879","author":"Martinotti","year":"2020","journal-title":"Front. Psychiatry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2147\/NDT.S107622","article-title":"Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: A single-center cross-sectional analysis of concurrently hospitalized patients","volume":"12","author":"Altintas","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Martinotti, G., Santacroce, R., Pettorruso, M., Montemitro, C., Spano, M.C., Lorusso, M., di Giannantonio, M., and Lerner, A.G. (2018). Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives. Brain Sci., 8.","DOI":"10.3390\/brainsci8030047"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archpsyc.62.2.137","article-title":"Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses","volume":"62","author":"Caton","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_39","unstructured":"von Weizs\u00e4cker, V. (1950). Gesammelte Schriften\/4 Der Gestaltkreis. Theorie der Einheit von Wahrnehmen und Bewegen, Suhrkamp."},{"key":"ref_40","unstructured":"Di Petta, G. (2004). Il mondo Tossicomane. Fenomenologia e Psicopatologia, FrancoAngeli."},{"key":"ref_41","first-page":"400","article-title":"Novel psychoactive substances and induced phenomena in psychopathology: The lysergic psychoma","volume":"21","author":"Martinotti","year":"2015","journal-title":"J. Psychopathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e2578","DOI":"10.1002\/hup.2578","article-title":"Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders: A multicenter-observational study","volume":"32","author":"Acciavatti","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"ref_43","first-page":"102","article-title":"Cognitive impairment in substance abuse","volume":"27","author":"Vik","year":"2004","journal-title":"Psychiatr. Clin. N. A."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1176\/appi.ajp.2017.17020223","article-title":"Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis","volume":"175","author":"Starzer","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/15504263.2016.1245457","article-title":"The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay","volume":"12","author":"Johnson","year":"2016","journal-title":"J. Dual Diagn."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/1874473711104040228","article-title":"Substance-Induced Psychoses: A Critical Review of the Literature","volume":"4","author":"Fiorentini","year":"2011","journal-title":"Curr. Drug Abus. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/hup.2312","article-title":"\u201cSpiceophrenia\u201d: A systematic overview of \u201cSpice\u201d-related psychopathological issues and a case report","volume":"28","author":"Papanti","year":"2013","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1017\/S1092852920001479","article-title":"Substance-related exogenous psychosis: A postmodern syndrome","volume":"26","author":"Martinotti","year":"2021","journal-title":"CNS Spectr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/PRBM.S114870","article-title":"Workplace violence in different settings and among various health professionals in an Italian general hospital: A cross-sectional study","volume":"9","author":"Ferri","year":"2016","journal-title":"Psychol. Res. Behav."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Chiappini, S., Vaccaro, G., Mosca, A., Miuli, A., Stigliano, G., Stefanelli, G., Giovannetti, G., Carullo, R., d\u2019Andrea, G., and Di Carlo, F. (2024). New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances. Neurosci. Biobehav. Rev., 162.","DOI":"10.1016\/j.neubiorev.2024.105691"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1177\/1359105316667795","article-title":"Alcohol drinking patterns in young people: A survey-based study","volume":"22","author":"Martinotti","year":"2017","journal-title":"J. Health Psycho."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Chiappini, S., Mosca, A., Miuli, A., Santovito, M.C., Orsolini, L., Corkery, J.M., Guirguis, A., Pettorruso, M., Martinotti, G., and Di Giannantonio, M. (2021). New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature. Medicina, 57.","DOI":"10.3390\/medicina57060580"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.2174\/1570159X21666221017085612","article-title":"Ibogaine\/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature","volume":"21","author":"Mosca","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/bcp.14209","article-title":"New psychoactive substances: Pharmacology influencing UK practice, policy and the law","volume":"86","author":"Nutt","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/YCO.0000000000000612","article-title":"Global strategy for New Psychoactive Substances: An update","volume":"33","author":"Vicknasingam","year":"2020","journal-title":"Curr. Opin. Psychiatry"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/10\/1387\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:15:31Z","timestamp":1760112931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/10\/1387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["ph17101387"],"URL":"https:\/\/doi.org\/10.3390\/ph17101387","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]}}}